• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过与已知生物活性化合物进行化学-化学相互作用分析发现的大肠杆菌化学探针。

Chemical probes of Escherichia coli uncovered through chemical-chemical interaction profiling with compounds of known biological activity.

作者信息

Farha Maya A, Brown Eric D

机构信息

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada.

出版信息

Chem Biol. 2010 Aug 27;17(8):852-62. doi: 10.1016/j.chembiol.2010.06.008.

DOI:10.1016/j.chembiol.2010.06.008
PMID:20797614
Abstract

While cell-based screens have considerable power in identifying new chemical probes of biological systems and leads for new drugs, a major challenge to the utility of such compounds is in connecting phenotype with a cellular target. Here, we present a systematic study to elucidate the mechanism of action of uncharacterized inhibitors of the growth of Escherichia coli through careful analyses of interactions with compounds of known biological activity. We studied growth inhibition with a collection of 200 antibacterial compounds when systematically combined with a panel of 14 known antibiotics of diverse mechanism and chemical class. Our work revealed a high frequency of synergistic chemical-chemical interactions where the interaction profiles were unique to the various compound pairs. Thus, the work revealed that chemical-chemical interaction data provides a fingerprint of biological activity and testable hypotheses regarding the mechanism of action of the novel bioactive molecules. In the study reported here, we determined the mode of action of an inhibitor of folate biosynthesis and a DNA gyrase inhibitor. Moreover, we identified eight membrane-active compounds, found to be promiscuously synergistic with known bioactives.

摘要

虽然基于细胞的筛选在识别生物系统的新化学探针和新药先导物方面具有相当大的作用,但此类化合物实用性的一个主要挑战在于将表型与细胞靶点联系起来。在此,我们通过仔细分析与已知生物活性化合物的相互作用,开展了一项系统性研究,以阐明未表征的大肠杆菌生长抑制剂的作用机制。当将一组200种抗菌化合物与一组14种已知的、作用机制和化学类别各异的抗生素系统地联合使用时,我们研究了其对生长的抑制作用。我们的工作揭示了高频的化学 - 化学协同相互作用,其中相互作用谱对于各种化合物对而言是独特的。因此,这项工作表明化学 - 化学相互作用数据提供了生物活性的指纹以及关于新型生物活性分子作用机制的可测试假设。在本文报道的研究中,我们确定了一种叶酸生物合成抑制剂和一种DNA促旋酶抑制剂的作用模式。此外,我们鉴定出了八种膜活性化合物,发现它们与已知生物活性物质普遍存在协同作用。

相似文献

1
Chemical probes of Escherichia coli uncovered through chemical-chemical interaction profiling with compounds of known biological activity.通过与已知生物活性化合物进行化学-化学相互作用分析发现的大肠杆菌化学探针。
Chem Biol. 2010 Aug 27;17(8):852-62. doi: 10.1016/j.chembiol.2010.06.008.
2
A novel DNA gyrase inhibitor rescues Escherichia coli dnaAcos mutant cells from lethal hyperinitiation.一种新型的 DNA 拓扑异构酶抑制剂可挽救致死性超起始的大肠杆菌 dnaAcos 突变细胞。
J Antimicrob Chemother. 2010 May;65(5):924-30. doi: 10.1093/jac/dkq071. Epub 2010 Mar 12.
3
Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.肺炎链球菌解旋酶ATP酶:一种用于抑制剂发现和表征的检测方法的开发与验证
Anal Biochem. 2007 Jun 1;365(1):132-43. doi: 10.1016/j.ab.2007.02.029. Epub 2007 Feb 27.
4
High-throughput screening of model bacteria.模式细菌的高通量筛选
Methods Mol Biol. 2009;486:13-27. doi: 10.1007/978-1-60327-545-3_2.
5
Experiments to demonstrate a synergistic action between sulfonamides or trimethoprim and 5-fluro-2'-deoxyuridine against Escherichia coli.
Arzneimittelforschung. 1974 Dec;24(12):1949-52.
6
Two short peptides including segments of subunit A of Escherichia coli DNA gyrase as potential probes to evaluate the antibacterial activity of quinolones.两种包含大肠杆菌DNA促旋酶A亚基片段的短肽,作为评估喹诺酮类抗菌活性的潜在探针。
J Pept Sci. 2001 Jan;7(1):27-40. doi: 10.1002/psc.292.
7
A 4.2 kDa synthetic peptide as a potential probe to evaluate the antibacterial activity of coumarin drugs.一种4.2千道尔顿的合成肽作为评估香豆素类药物抗菌活性的潜在探针。
J Pept Sci. 2004 Sep;10(9):566-77. doi: 10.1002/psc.565.
8
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activity.DNA 回旋酶(GyrB)/拓扑异构酶 IV(ParE)抑制剂:合成与抗菌活性。
Bioorg Med Chem Lett. 2009 Feb 1;19(3):894-9. doi: 10.1016/j.bmcl.2008.11.102. Epub 2008 Dec 3.
9
Structure and antimicrobial activity of some new norfloxacin and ofloxacin divalent metal ion complexes.一些新型诺氟沙星和氧氟沙星二价金属离子络合物的结构与抗菌活性
Roum Arch Microbiol Immunol. 2001 Jul-Sep;60(3):267-77.
10
DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.细菌染色体上的DNA促旋酶和拓扑异构酶IV:喹诺酮诱导的DNA切割
J Mol Biol. 1996 May 17;258(4):627-37. doi: 10.1006/jmbi.1996.0274.

引用本文的文献

1
Chemical genetic approaches for the discovery of bacterial cell wall inhibitors.用于发现细菌细胞壁抑制剂的化学遗传学方法。
RSC Med Chem. 2023 Aug 30;14(11):2125-2154. doi: 10.1039/d3md00143a. eCollection 2023 Nov 15.
2
Systematic Prediction of Antifungal Drug Synergy by Chemogenomic Screening in .通过化学基因组学筛选对……中抗真菌药物协同作用进行系统预测
Front Fungal Biol. 2021 Jul 2;2:683414. doi: 10.3389/ffunb.2021.683414. eCollection 2021.
3
Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemia.
开发组成协同纳米制剂以提高 T 细胞白血病的化疗敏感性。
J Control Release. 2023 Sep;361:470-482. doi: 10.1016/j.jconrel.2023.07.045. Epub 2023 Aug 14.
4
High-Throughput Screening of Natural Product and Synthetic Molecule Libraries for Antibacterial Drug Discovery.用于抗菌药物发现的天然产物和合成分子文库的高通量筛选
Metabolites. 2023 May 2;13(5):625. doi: 10.3390/metabo13050625.
5
Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus.与头孢托罗匹酯协同作用的 FDA 批准药物对耐甲氧西林金黄色葡萄球菌的联合治疗。
Microbiol Spectr. 2023 Feb 14;11(1):e0372622. doi: 10.1128/spectrum.03726-22. Epub 2022 Dec 15.
6
Potential Synergistic Antibiotic Combinations against Fluoroquinolone-Resistant .针对耐氟喹诺酮类药物的潜在协同抗生素组合
Pharmaceuticals (Basel). 2022 Feb 18;15(2):243. doi: 10.3390/ph15020243.
7
Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota.药物、天然化合物和污染物与肠道微生物群的多模式相互作用。
Nat Rev Microbiol. 2022 Jul;20(7):431-443. doi: 10.1038/s41579-022-00681-5. Epub 2022 Jan 31.
8
The pursuit of mechanism of action: uncovering drug complexity in TB drug discovery.作用机制的探索:揭示结核病药物研发中的药物复杂性
RSC Chem Biol. 2021 Apr 1;2(2):423-440. doi: 10.1039/d0cb00226g. Epub 2021 Jan 13.
9
Use of a Fluorescence-Based Assay To Measure Escherichia coli Membrane Potential Changes in High Throughput.使用基于荧光的检测方法高通量测量大肠杆菌膜电位变化。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.00910-20.
10
Additive Dose Response Models: Defining Synergy.加性剂量反应模型:协同作用的定义
Front Pharmacol. 2019 Nov 26;10:1384. doi: 10.3389/fphar.2019.01384. eCollection 2019.